Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Price-Fixing Conspiracies: Taro Pharma former executive faces probe in US

      Price-Fixing Conspiracies: Taro Pharma former executive faces probe in US

      Medical Dialogues Bureau6 Feb 2020 12:00 PM IST
      The Justice Department said that former sales and marketing executive of Taro Pharma, Aprahamian was indicted on Tuesday for participating in two...
      Sanofi being probed over birth defects related to Epilepsy drug Depakine

      Sanofi being probed over birth defects related to Epilepsy drug Depakine

      Medical Dialogues Bureau5 Feb 2020 3:35 PM IST
      The Paris prosecutor had already launched a preliminary investigation into the authorisation and marketing of Depakine in 2016, after France's...
      JnJ Faulty Hip Implants: 171 patients received compensation, says Ashwini Kumar Choubey

      JnJ Faulty Hip Implants: 171 patients received compensation, says Ashwini Kumar Choubey

      Medical Dialogues Bureau5 Feb 2020 3:15 PM IST
      "Based on the court order, a list of verified claimants along with supporting documents has been provided to Johnson and Johnson for complying with...
      Granules India arm gets USFDA nod for generic version of  Valcyte

      Granules India arm gets USFDA nod for generic version of Valcyte

      Medical Dialogues Bureau5 Feb 2020 3:13 PM IST
      Valganciclovir hydrochloride oral solution is bioequivalent to the reference listed drug product (RLD), Valcyte for Oral Solution, 50mg/mL, OF Roche...
      Sun Pharma unveils acne drug Absorica LD in US

      Sun Pharma unveils acne drug Absorica LD in US

      Medical Dialogues Bureau5 Feb 2020 11:41 AM IST
      "The launch of Absorica LD - which offers the proven efficacy and safety of Absorica at a lower dose - underscores our commitment to making a...
      Divis Labs Chippada facility gets zero USFDA observations

      Divis Labs Chippada facility gets zero USFDA observations

      Medical Dialogues Bureau4 Feb 2020 9:45 AM IST
      "This is to inform you that the Company's Unit-II at Village Chippada, Bheemunipatnam District, Andhra Pradesh has had an inspection by the US Food...
      GSK, CEPI collaborate to develop vaccine for 2019-nCoV virus

      GSK, CEPI collaborate to develop vaccine for 2019-nCoV virus

      Medical Dialogues Bureau4 Feb 2020 9:30 AM IST
      Both CEPI and GSK are committed to principles of equitable access and will work together in this collaboration to ensure that this principle governs...
      Novacyt unveils new coronavirus test

      Novacyt unveils new coronavirus test

      Medical Dialogues Bureau2 Feb 2020 9:30 AM IST
      Novacyt said its Primerdesign coronavirus test could detect the 2019 strain of the virus, adding it believed this would differentiate it from other...
      Abbott bags European nod for Tendyne Transcatheter Mitral Valve Implantation system

      Abbott bags European nod for Tendyne Transcatheter Mitral Valve Implantation system

      Medical Dialogues Bureau1 Feb 2020 1:00 PM IST
      New Delhi: Abbott today announced that its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system received CE Mark and is now approved for use...
      Gilead offers to test Ebola drug remdesivir as new coronavirus treatment in China

      Gilead offers to test Ebola drug remdesivir as new coronavirus treatment in China

      Medical Dialogues Bureau1 Feb 2020 12:38 PM IST
      Gilead Sciences Inc said it was also expediting laboratory testing of the antiviral drug, remdesivir, against samples of the new coronavirus, which...
      Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

      Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

      Medical Dialogues Bureau1 Feb 2020 9:45 AM IST
      Drug firm Jubilant Life Sciences on Friday reported a 23.97 per cent fall in consolidated net profit at Rs 203.38 crore for the third quarter ended...
      NPPA fixes price of 17 formulations including BP drugs,painkillers; details

      NPPA fixes price of 17 formulations including BP drugs,painkillers; details

      Medical Dialogues Bureau31 Jan 2020 4:49 PM IST
      New Delhi : Through a recent notice, the National Pharmaceutical Pricing Authority,Ministry of Chemicals and Fertilizers,Government of India has fixed...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok